Structure-activity relationship of coordinated catecholamine in the [RuIII(NH3)4(catecholamine)]+ complex

International Journal of Pharmaceutics

Volumn 271, Issue 1-2, 2004, Pages 21-30

  De Lima, Renata Galvão ^a   Pereira Marchesi, Mario Sérgio ^b   De Godoy, Márcio Augusto Fressatto ^a   Cassano, Adriano Oliano ^b   De Oliveira, Ana Maria ^a   Da Silva, Roberto Santana ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Faculdade Cie Farmaceuticas R   (Brazil)

Author keywords

Catecholamines; Dioxolene ligands; Quinone; Ruthenium(III) complexes

Indexed keywords

CATECHOLAMINE; DOPAMINE; ISOPRENALINE; NORADRENALIN; RUTHENIUM COMPLEX;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; ELECTROCHEMISTRY; HORMONE STRUCTURE; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTON TRANSPORT; RAT; STRUCTURE ACTIVITY RELATION;

EID: 1142285526     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.10.018     Document Type: Article

References (22)

1. Allen A.D., Senoff C.V. Preparation and infrared spectra of some amine complexes of ruthenium(II) and ruthenium(III). Can. J. Chem. 45:1967;1337.
2. Barger G., Dale H.H. Chemical structure and sympathomimetic action of amines. J. Physiol. 41:1910;19-59.
3. Brun A., Rosset R. Electrochimique de l'oxydation de la dihydroxy-3,4-phénylalanine (dopa). J. Electroanal. Chem.Interf. Electrochem. 49:1974;287-300.
4. Cavalli A., Fanelli F., Taddei C., De Benedetti P.G., Cotecchia S. Amino acids involved in agonist binding: differences in docking catecholamines to receptor subtypes. FEBS Lett. 399:1996;9-13.
5. 1b-adrenergic receptor subtypes: molecular mechanism of receptor activation and of drug action. Pharm. Acta Helv. 74:2000;173-179.
6. 2+ transport due to excess catecholamines. Cardiovasc. Drugs Ther. 10:1996;231-238.
7. Drukarch B., Van Muiswinkel F.L. Drug treatment of Parkinson's disease. Biochem. Pharmacol. 59:2000;1023-1031.
8. Gillespie J.S. The rat anococcygeus muscle and its response to nerve stimulation and to some drugs. Br. J. Pharmacol. 45:1972;404-416.
9. 1-adrenergic receptor agonista binding and activation. J. Biol. Chem. 271:1996;6322-6327.
10. Hawley M.D., Tatawawadi S.V., Pickarski S., Adams R.N. Electrochemical studies of oxidation pathways of catecholamines. J. Am. Chem. Soc. 89:1967;447.
11. Lima R.G., Lever A.B.P., Ito I.Y., Silva R.S. Antifungal activity of novel catecholamine ruthenium(III) complexes. Trans. Met. Chem. 28:2003;272-275.
12. Linert W., Jameson G.N.L. Redox reactions of neurotransmitters possibly in the progression of Parkinson's disease. J. Inorg. Biochem. 79:2000;319-326.
13. Martinez-Alvarado P., Dagnino-Subiabre A., Paris I., Metodiewa D., Welch C.J., Olea-Azar C., Ceviedes P., Ceviedes R., Segura-Aguilar J. Possible role of slasolinol quinone methide in the decrease of RCSN-3 cell survival. Biochem. Biophys. Res. Commun. 283:2001;1069-1076.
14. Nicholson R.S., Shain I. Theory of stationary electrode polarography for a chemical reaction coupled between two charge transfers. Anal. Chem. 37:1965;178.
15. Remião F., Carmo H., Carvalho F., Bastos M.L. Copper enhances isoproternol toxicity in isolated rat cardiomyocytes: effects on oxidative stress. Cardiovasc. Toxicol. 1:2001;195-204.
16. 2+-induced isoproterenol oxidation into isopronochrome in adult rat calcium-tolerant cardiomyocytes. Chem. Res. Toxicol. 15:2002;861-869.
17. Riobó N.A., Schopfer F.J., Boveris A.D., Cadenas E., Poderoso J.J. The reaction of nitric oxide with 6-hydroxy-dopmaine: implications for Parkinson's disease. Free Radic. Biol. Med. 32:2002;115-121.
18. Rupp H., Dhalla N.S. Mechanism of cardiac cell damage due to catecholamines: significance of drugs regulation central sympathetic outflow. J. Cardiovasc. Pharmacol. 24:1994;S16-S24.
19. Senoh S., Witkop B. Formation and rearrangements of aminochromes from a new metabolites of dopamine and some of its derivates. J. Am. Chem. Soc. 81:1959;6231-6235.
20. n+ species containing ruthenium(II) or ruthenium(III) using tetrammino (3,4- diolatobenzoato)ruthenium(II) as precursor. Inorg. Chim. Acta. 235:1995;427-430.
21. Silva R.S., Gorelski S.I., Dodsworth E.S., Tfouni E., Lever A.B.P. Synthesis, spectral and redox properties of tetraammine dioxolene ruthenium complexes. J. Chem. Soc. Dalton Trans. 22:2000;4078-4088.
22. Wightman R.M., May L.J., Michael A.C. Detection of dopamine dynamics in the brain. Anal. Chem. 60:1988;A769.